(Total Views: 912)
Posted On: 04/01/2019 4:15:40 PM
Post# of 64
$AVEO News Article - AVEO and Biodesix Announce Positive Results from Phase Ib Ficlatuzumab-Cytarabine Trial in Patients with Relapsed and Refractory AML https://marketwirenews.com/news-releases/aveo...26098.html
(1)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
